BMY

Got $500? 3 Dividend-Paying Healthcare Stocks to Buy and Hold Forever

12/30 10:15 am

3 Drug Stocks to Buy at a Discount

12/27 05:28 pm

Got $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Forever

12/24 06:26 pm

Should Retirees Pull Their Money Out of the Stock Market in 2026?

12/21 05:30 am

Immuno-oncology Clinical Trials Market Projected to Reach USD 23.63 Billion by 2032 at a CAGR of 12.37% - SNS Insider

12/14 09:32 am

Want Decades of Passive Income? Buy This Index Fund and Hold It Forever.

12/14 06:15 am

BioNTech-Bristol Drug Shows Hope For Breast Cancer Patients With Few Options

12/09 01:38 pm

Antibody Discovery Market to Reach USD 17.68 Billion by 2032, Driven by Rising Demand for Targeted Therapies and Advancements in AI Powered Antibody Engineering – SNS Insider

12/07 10:26 am

Do These 3 Healthcare Stocks Need a Checkup?

12/05 05:05 pm

CAR T-Cell Therapy Market Industry Trends and Global Forecasts to 2035 by Target Antigens, Target Indication, Key Geographies, Sales Forecast of Drugs and Leading Players

12/05 06:41 am

Bristol Myers Pushes Data Readout For Key Alzheimer's Psychosis Study After Irregularities

12/03 02:51 pm

2 Undervalued, High-Quality Companies to Buy Now and Hold Forever

11/30 10:05 pm

2 Top Dividend Stocks to Buy and Hold

11/30 05:05 am

Should You Buy Bristol Myers Stock for Its 5.4%-Yielding Dividend?

11/29 07:18 am

Geriatric Care Services Market is expected to generate a revenue of USD 2.03 Billion by 2032, Globally, at 7.98% CAGR: Verified Market Research®

11/27 11:50 pm

Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study

11/24 02:14 pm

Metabolic Collaboration and Licensing Agreements Analysis Report and Directory 2025: Upfront, Milestone, and Royalties for 576 Deals by Company A-Z, Therapy Focus and Technology Type

11/19 11:58 am

Bristol Myers Faces Another Trial Disappointment As Heart Drug Milvexian Fails To Show Efficacy

11/14 12:17 pm

The Market’s a Ripoff Right Now, but These 4 High Yielders Aren’t

11/14 06:37 am

Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run

11/13 12:10 pm

CytomX Therapeutics to Present at the Jefferies London Healthcare Conference

11/13 09:00 am

Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates

11/07 08:00 am

CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025

10/30 08:00 am

Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer

10/28 08:00 am

Avidity Shareholders Win Big As Novartis Moves Fast On $12 Billion Deal

10/27 06:11 am

Small Cell Lung Cancer Market Research 2025-2035: Growth Driven by Advancements in Novel Therapies, Including Immunotherapies, Targeted Therapies, and Combination Treatments

10/21 04:41 am

Why Replimune Stock Was Soaring Today

10/20 04:10 pm

Replimune Highlights Acral Melanoma Data for RP1 plus Nivolumab at the ESMO Congress 2025

10/19 08:00 am

This Drug Discovery Stock Is Leading the Charge In Bringing AI to Healthcare. But Is It a Buy?

10/16 04:31 am

Pancreatic Endocrine Tumor Market Set to Witness Significant Growth During the Forecast Period (2025–2034) Owing to the Expected Launch of Therapies | DelveInsight

10/13 01:00 pm

Mechanobiology-Centered Therapy Market Insights and Growth Outlook by Towards Healthcare

10/13 09:00 am

Bristol Myers Expands Cell Therapy Portfolio With Orbital Therapeutics Acquisition

10/10 10:32 am

CAR T-Cell Therapy for Multiple Myeloma Market to Witness Upsurge in Growth by 2034 Owing to the Launch of Emerging Therapies | DelveInsight

10/08 01:00 pm

Multiple Myeloma CAR-T Market Set for Rapid Growth Driven by BCMA-Targeted Therapies and Innovative Advances

10/08 11:00 am

Multiple Modalities in the Oncology Market Size, Regional Growth and Trends

09/30 11:00 am

Revolution Medicines Announces Key Leadership Additions, including Alan Sandler, M.D. as Chief Development Officer

09/29 09:00 am

Bristol Myers Squibb Franchise Gains Momentum With Phase 3 Results In Multiple Myeloma Patients

09/23 01:07 pm

Thalassemia Treatment Market to Witness Significant Growth by 2034 Driven by Novel Drug Development | DelveInsight

09/22 01:00 pm

Ectopic Pregnancy Market Set to Surge USD 16.09 Billion by 2034, Driven by Rising Awareness and Early Detection

09/22 09:00 am

Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises

09/18 08:45 am

Johnson & Johnson, Protagonist Study Shows Superior Skin Clearance In Psoriasis Trials

09/17 03:15 pm

Advancing Cancer Research Brings New Hope for Patients Worldwide

09/17 08:30 am

Bipolar Disorder Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight

09/11 01:00 pm

A Landmark Pivotal Study Applying Precision Medicine to Psychiatry with Denovo’s DB104 (liafensine) for Treatment-Resistant Depression Published in JAMA Psychiatry

09/11 07:00 am

The Best Ultra-High-Yield Dividend Stock to Invest $1,000 in Right Now

09/09 06:05 am

BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy

09/08 02:01 pm

Erste Zwischenergebnisse aus BioNTechs und BMS‘ globaler Phase-2-Studie mit bispezifischem PD-L1xVEGF-A-Antikörperkandidat Pumitamig (BNT327/BMS986545) zeigen ermutigende Anti-Tumor-Aktivität bei fortgeschrittenem kleinzelligem Lungenkrebs

09/08 11:00 am

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

09/08 11:00 am

Is Pfizer a Millionaire Maker?

09/07 09:30 am

Multiple Myeloma Market Size Projected USD 49.89 Billion by 2034

09/03 11:00 am